136 related articles for article (PubMed ID: 37256702)
21. Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report.
Minami K; Jimbo N; Tanaka Y; Hokka D; Miyamoto Y; Itoh T; Maniwa Y
Virchows Arch; 2020 Mar; 476(3):469-473. PubMed ID: 31667596
[TBL] [Abstract][Full Text] [Related]
22. Malignant pleural mesothelioma presenting with a spontaneous hydropneumothorax: a report of 2 cases.
Saleh HZ; Fontaine E; Elsayed H
Rev Port Pneumol; 2012; 18(2):93-5. PubMed ID: 21924581
[TBL] [Abstract][Full Text] [Related]
23. Multicenter study of diffuse pleural mesothelioma. Histopathological and immunohistochemical features.
Poleri C; Acosta Haab G; Falcoff N; Guman G; Dalurzo L; Iotti A; Martín ME; Olmedo G; Rayá M; Reginatto A; Werbach A; Demelli G; Labanca MJ; Leguina L; Mora MF
Medicina (B Aires); 2022; 82(2):210-216. PubMed ID: 35417384
[TBL] [Abstract][Full Text] [Related]
24. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.
Kinoshita Y; Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Hiroshima K; Oda Y; Nabeshima K
Cancer Cytopathol; 2018 Jan; 126(1):54-63. PubMed ID: 29053210
[TBL] [Abstract][Full Text] [Related]
25. The cytological features of effusions with mesothelioma in situ: A report of 9 cases.
Michael CW; Bedrossian CCWM; Sadri N; Klebe S
Diagn Cytopathol; 2023 Jun; 51(6):374-388. PubMed ID: 36942732
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry.
Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Iwasaki A; Okamoto T; Oda Y; Honda H; Nabeshima K
Lung Cancer; 2017 Feb; 104():98-105. PubMed ID: 28213009
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous detachment of benign mesothelioma into the pleural space and removal during pleuroscopy.
Mengeot PM; Gailly C
Eur J Respir Dis; 1986 Feb; 68(2):141-5. PubMed ID: 3699116
[TBL] [Abstract][Full Text] [Related]
28. Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting.
Li Y; Salama AM; Baine MK; Bodd FM; Offin MD; Rekhtman N; Zauderer MG; Travis WD; Adusumilli PS; Sauter JL
Cancer Cytopathol; 2023 Aug; 131(8):495-506. PubMed ID: 37127928
[TBL] [Abstract][Full Text] [Related]
29. [Spontaneous pneumothorax. Graduated concept of surgical therapy].
Kupczyk-Joeris D; Schumpelick V
Zentralbl Chir; 1992; 117(5):247-52. PubMed ID: 1322613
[TBL] [Abstract][Full Text] [Related]
30. Analysis of early pleural fluid samples in patients with mesothelioma: A case series exploration of morphology, BAP1, and CDKN2A status with implications for the concept of mesothelioma in situ in cytology.
Louw A; van Vliet C; Peverall J; Colkers S; Acott N; Creaney J; Lee YCG; Chai SM
Cancer Cytopathol; 2022 May; 130(5):352-362. PubMed ID: 35143119
[TBL] [Abstract][Full Text] [Related]
31. [Bilateral pneumothorax in diffuse mesothelioma].
Haas P; Huber W
Wien Klin Wochenschr; 1969 Jun; 81(25):473-5 passim. PubMed ID: 5809154
[No Abstract] [Full Text] [Related]
32. Simultaneous bilateral spontaneous pneumothorax in a patient with peritoneal and pleural papillary mesothelioma.
Höllinger P; Gaeng D
Respiration; 1997; 64(3):233-5. PubMed ID: 9154677
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens.
Berg KB; Churg AM; Cheung S; Dacic S
Cancer Cytopathol; 2020 Feb; 128(2):126-132. PubMed ID: 31821740
[TBL] [Abstract][Full Text] [Related]
34. [Dysphagia as an unusual form of presentation of malignant pleural mesothelioma].
Mendoza H; Huarte MP; Iglesias R; Lozano A; Jiménez C; Aizcorbe M; Almudevar E
Rev Esp Enferm Dig; 1996 Mar; 88(3):217-20. PubMed ID: 8645517
[TBL] [Abstract][Full Text] [Related]
35. Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia.
Yoshimura M; Kinoshita Y; Hamasaki M; Matsumoto S; Hida T; Oda Y; Iwasaki A; Nabeshima K
Lung Cancer; 2019 Apr; 130():187-193. PubMed ID: 30885343
[TBL] [Abstract][Full Text] [Related]
36. [A case of malignant mesothelioma presenting with recurrent pneumothorax].
Katayam N; Tokuda A; Nakatsumi Y; Oribe Y; Fujimura M
Nihon Kokyuki Gakkai Zasshi; 2006 Nov; 44(11):807-11. PubMed ID: 17144577
[TBL] [Abstract][Full Text] [Related]
37. Sarcomatoid mesothelioma originating from mesothelioma in situ: are methylthioadenosine phosphorylase loss and CDKN2A homozygous deletion poor prognostic factors for preinvasive mesothelioma?
Nishikubo M; Jimbo N; Tanaka Y; Tachihara M; Itoh T; Maniwa Y
Virchows Arch; 2022 Aug; 481(2):307-312. PubMed ID: 35043235
[TBL] [Abstract][Full Text] [Related]
38. [Localized fibrous mesothelioma with bloody pleural effusion; report of a case].
Ogata K; Sakakibara K; Hirano R; Nishiumi N; Tsutsumi M; Ishihara S; Namikawa S
Kyobu Geka; 2004 Feb; 57(2):159-62. PubMed ID: 14978915
[TBL] [Abstract][Full Text] [Related]
39. Mesothelioma in situ with regressive malignant pleural effusion and an unexpected evolution: A case report.
Almeida GC; Santos UP; Parente YDM; Colares PFB; Mizutani RF; Bernardi FDC; Terra RM; Terra-Filho M
Am J Ind Med; 2022 Jul; 65(7):620-623. PubMed ID: 35524457
[TBL] [Abstract][Full Text] [Related]
40. [Localized Malignant Mesothelioma of the Pleura with Hemothorax].
Mega S
Kyobu Geka; 2016 Mar; 69(3):218-21. PubMed ID: 27075290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
